These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 2661281

  • 21. Insulin treatment improved glucose-induced insulin release in elderly non-insulin-dependent diabetes mellitus, secondary failure to oral hypoglycemic agents.
    Jap TS, Kwok CF, Won JG, Ho LT.
    Zhonghua Yi Xue Za Zhi (Taipei); 1991 May; 47(5):320-4. PubMed ID: 1649673
    [Abstract] [Full Text] [Related]

  • 22. Beta cell function in long term NIDDM (type 2) patients and its relation to treatment.
    Snehalatha C, Ramachandran A, Mohan V, Timothy H, Viswanathan M.
    Horm Metab Res; 1986 Jun; 18(6):391-4. PubMed ID: 3525362
    [Abstract] [Full Text] [Related]

  • 23. Short-term effects of continuous subcutaneous insulin infusion treatment on insulin secretion in non-insulin-dependent overweight patients with poor glycaemic control despite maximal oral anti-diabetic treatment.
    Valensi P, Moura I, Le Magoarou M, Pariès J, Perret G, Attali JR.
    Diabetes Metab; 1997 Feb; 23(1):51-7. PubMed ID: 9059766
    [Abstract] [Full Text] [Related]

  • 24. [Immunologic and insulin secretion markers in non insulin dependent diabetic patients with secondary failure to oral hypoglycemic drugs].
    Maiz A, Manrique M, Arteaga A, Acosta AM, Andrade L.
    Rev Med Chil; 1995 Oct; 123(10):1199-203. PubMed ID: 8733310
    [Abstract] [Full Text] [Related]

  • 25. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R, Odetti P, Melga P, Giusti R, Ciuchi E, Cheli V.
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [Abstract] [Full Text] [Related]

  • 26. Oral hypoglycaemic agent failure.
    Banerjee S, Sinharoy K, Singh AK.
    J Indian Med Assoc; 2002 Jul; 100(7):452-6. PubMed ID: 12674170
    [Abstract] [Full Text] [Related]

  • 27. C-peptide profiles in patients with non-insulin-dependent diabetes mellitus before and during insulin treatment.
    Lindström T, Arnqvist HJ, Ludvigsson J, von Schenck HH.
    Acta Endocrinol (Copenh); 1992 Jun; 126(6):477-83. PubMed ID: 1642079
    [Abstract] [Full Text] [Related]

  • 28. Beta cell function in insulin-treated non-insulin-dependent diabetic patients.
    Ramachandran A, Snehalatha C, Mohan V, Rao CA, Viswanathan M.
    Pancreas; 1986 Jun; 1(5):411-4. PubMed ID: 3550785
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of insulin therapy on non-insulin-dependent diabetics with secondary oral hypoglycemic agent failure.
    Peng YS, Juang JH.
    Changgeng Yi Xue Za Zhi; 1998 Sep; 21(3):271-6. PubMed ID: 9849007
    [Abstract] [Full Text] [Related]

  • 31. Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents.
    Chuang LM, Lu C, Su RJ, Wu HP, Tai TY, Lin BJ.
    J Formos Med Assoc; 1992 Feb; 91(2):185-9. PubMed ID: 1364216
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence].
    Seclén Santisteban S, Alvarez Huamán RI, Chantres Antoranz MT, Serrano Ríos M.
    Rev Clin Esp; 1993 Mar; 192(4):162-8. PubMed ID: 8480059
    [Abstract] [Full Text] [Related]

  • 35. Modulation of insulin secretion in non-insulin-dependent diabetes mellitus by two novel oral hypoglycaemic agents, NN623 and A4166.
    Kikuchi M.
    Diabet Med; 1996 Sep; 13(9 Suppl 6):S151-5. PubMed ID: 8894500
    [Abstract] [Full Text] [Related]

  • 36. Combination therapy of glibenclamide and insulin in NIDDM patients with secondary failure to oral drugs.
    Mohan V, Snehalatha C, Ramachandran A, Viswanathan M.
    J Assoc Physicians India; 1990 Aug; 38(8):537-41. PubMed ID: 2123183
    [Abstract] [Full Text] [Related]

  • 37. C-peptide response to glucagon challenge is correlated with improvement of early insulin secretion by liraglutide treatment.
    Takabe M, Matsuda T, Hirota Y, Hashimoto N, Nakamura T, Sakaguchi K, Ogawa W, Seino S.
    Diabetes Res Clin Pract; 2012 Dec; 98(3):e32-5. PubMed ID: 23068961
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.